Follow
Owen M O'Connor
Owen M O'Connor
Verified email at bu.edu
Title
Cited by
Cited by
Year
DeLTA 2.0: A deep learning pipeline for quantifying single-cell spatial and temporal dynamics
OM O˘Connor, RN Alnahhas, JB Lugagne, MJ Dunlop
PLoS computational biology 18 (1), e1009797, 2022
582022
The motility regulator flhDC drives intracellular accumulation and tumor colonization of Salmonella
V Raman, N Van Dessel, OM O˘Connor, NS Forbes
Journal for ImmunoTherapy of Cancer 7, 1-16, 2019
222019
Longitudinal Single‐Cell Imaging of Engineered Strains with Stimulated Raman Scattering to Characterize Heterogeneity in Fatty Acid Production
N Tague, H Lin, JB Lugagne, OM O'Connor, D Burman, WW Wong, ...
Advanced Science 10 (20), 2206519, 2023
32023
Implantable devices for cell therapy and related methods
LE Barney, M Beauregard, G Carmona, FC Gonzalez, R Heidebrecht, ...
US Patent App. 17/280,802, 2022
12022
Implantable particles and related methods
LE Barney, M Beauregard, G Carmona, FC Gonzalez, R Heidebrecht, ...
US Patent App. 17/045,127, 2021
12021
Compositions, devices, and methods for factor vii therapy
LE Barney, M Beauregard, G Carmona, FC Gonzalez, R Heidebrecht, ...
US Patent App. 17/598,154, 2023
2023
Longitudinal single-cell chemical imaging of engineered strains reveals heterogeneity in fatty acid production
N Tague, H Lin, JB Lugagne, OM O˘Connor, D Burman, WW Wong, ...
bioRxiv, 2022
2022
Compositions, devices, and methods for treating fabry disease
LE Barney, M Beauregard, G Carmona, FC Gonzalez, R Heidebrecht, ...
US Patent App. 17/598,176, 2022
2022
Correcting bleeding disorders using blood clotting factors produced in vivo by shielded engineered allogeneic cells
G Carmona, L Barney, J Sewell, R Newman, C Carroll, O O'Connor, ...
HUMAN GENE THERAPY 30 (11), A192-A192, 2019
2019
Correcting Bleeding Disorders Using Blood Clotting Factors Produced by Shielded Engineered Allogenic Cells
G Carmona, L Barney, J Sewell, R Newman, C Carroll, O O'Connor, ...
MOLECULAR THERAPY 27 (4), 338-338, 2019
2019
Enzyme Replacing Therapy in MPS-1 Mice by Enzyme Produced In Vivo by Shielded Engineered Allogeneic Cells
E Makino, B Fluharty, D Tietz, L Barney, J Sewell, C Carroll, J Huang, ...
MOLECULAR THERAPY 27 (4), 241-242, 2019
2019
Correcting hemophilia A using human FVIII produced in vivo by Afibromer (TM) shielded engineered allogeneic cells
G Carmona, L Barney, J Sewell, R Newman, C Carroll, O O'Connor, ...
HAEMOPHILIA 25, 98-98, 2019
2019
Intracellular Invasion of Salmonella Drives Tumor Colonization of the Bacteria in vitro
V Raman, N Van Dessel, O O'Connor, NS Forbes
2017 AIChE Annual Meeting, 2017
2017
Upregulation of Salmonella motility in tumors improves dispersion, colonization and intracellular invasion of the bacteria
V Raman, NV Dessel, O O'Connor, NS Forbes
Cancer Research 77 (13_Supplement), 5136-5136, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–14